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Summary
Objective: To assess the influence of intra-articular injection of hyaluronan (HA) on expression of matrix
metalloproteinase-3 (MMP-3), interleukin-1â (IL-1â), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in cartilage
and synovium during the process of osteoarthritis (OA).
Design: Eighteen mature New Zealand white rabbits underwent unilateral anterior cruciate ligament transection
(ACLT) and were divided into two groups. The first group (HA injection group) received 0.3 ml of intra-articular HA
injections into the ACLT knees 4 weeks after transection, once a week for 5 weeks as per clinical treatment presently
utilized. The animals in the second group (no injection group) were not injected after ACLT. At death, 9 weeks
following surgery, synovium and cartilage were harvested and total RNA was extracted. Gene expressions of MMP-3,
IL-1â and TIMP-1 were analyzed using reverse transcription-polymerase chain reaction (RT-PCR) for each subgroup
created according to morphological grade of OA.
Results: The extent and grade of cartilage damage in the HA injection group was less severe than in the no injection
group. In synovium, expression of MMP-3 and IL-1â mRNA was suppressed in the mild grades of OA in the HA
injection group. HA treatment had either no e#ect on MMP-3 expression in cartilage at all grades of OA or on
enhanced MMP-3 and IL-1â expression in synovium at a progressed grade. No e#ect of HA treatment on TIMP-1
expression was observed in either cartilage or synovium.
Conclusions: These results suggest that one of the mechanism of therapeutic e#ect of HA is down-regulation of
MMP-3 and IL-1â in synovium during early development of OA.
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OSTEOARTHRITIS (OA) is a degenerative joint disease
resulting in cartilage erosion, subchondral bone
remodeling, osteophyte formation, and synovial
inflammation. Although OA might have multiple
origins, current evidence suggests that both mech-
anical and biochemical factors play an important
role in its progression.
Matrix metalloproteinases (MMPs) synthesized
and secreted from connective tissue cells have
been thought to participate in the degradation of
extracellular matrix since many of them have their182optimum enzymic activity around physiological
pH. In fact, increased MMP activities that degrade
proteoglycans have been measured in OA cartilage
in human [1] and experimental animal models [2].
Among MMPs, MMP-3 (stromelysin) degrades
several extracellular matrix molecules, including
cartilage proteoglycan and type II collagen [3, 4].
Tissue inhibitor of metalloproteinase (TIMP) is
a glycoprotein and inhibits all MMPs on a 1:1
basis by forming high-a$nity complexes [5]. TIMP
was not elevated in OA cartilage and synovium as
much as MMPs [1, 6]. An imbalance between the
activities of MMPs and TIMP is thought to be
important in the progression of OA.
Among the proinflammatory cytokines,
interleukin-1â (IL-1â) is abundantly synthesized by
OA synovium [7] and cartilage [8]. IL-1â induces
the expression of MMP-3 [9] as well as prostaglan-
din [10] and inhibits the formation of extracellularReceived 17 March 1998; accepted 18 August 1998.
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cyte proliferation and induces in chondrocytes the
production of high levels of nitric oxide (NO) and
apoptosis [12, 13]. IL-1â appears to be primarily
responsible for cartilage catabolism.
Intra-articular injection of hyaluronan (HA) is
now widely used in the treatment of OA. Hyaluro-
nan, one of the principal components of cartilage
matrix, has been reported to have a positive e#ect
on the maintenance of cartilage matrix integrity
during the development of OA [14, 15]. Exogenous
HA, previously used simply as a lubricative agent,
has been shown to delay degradation of cartilage
by inhibiting glycosaminoglycan (GAG) release
from cartilage tissue [16] and has antiinflamma-
tory e#ects [17, 18]. However, the mechanisms of
such therapeutic e#ect of HA on OA remains to be
elucidated. In this study, we are investigating the
mechanisms of e#ects of HA on OA; expression of
MMP-3, IL-1â, and TIMP-1 mRNA was assessed
in the articular cartilage and synovium of exper-
imentally induced OA rabbits with or without
intra-articular injection of HA.
Materials and methods
ANIMALS
Eighteen mature New Zealand White rabbits
underwent unilateral anterior cruciate ligament
transection (ACLT). According to a protocol
approved by the UCSD Institutional Review
Board, ACLT was performed using a medial
arthrotomy method [19]. Postoperatively the ani-
mals were permitted cage (60 cm#60 cm#40 cm)
activity without immobilization. We divided the
animals into two groups. The first group (HA
injection group, N=10) received 0.3 ml of intra-
articular HA (MW=8#105, 10 mg/ml, Seikagaku
Corp., Tokyo, Japan) injections into the operated
knees 4 weeks after ACLT, once a week for 5 weeks
as per clinical treatment presently utilized. The
second group (no injection group, N=8) was not
injected after ACLT. All animals were killed at
9 weeks following surgery. Four untreated rabbits
were used as normal controls.
GROSS MORPHOLOGY
At death, all operated knees were evaluated for
gross morphological changes in the cartilage. The
femoral condyles were photographed using a
35-mm camera equiped with a close-up micro lens.
Gross morphological changes of the femoral con-
dyles were assessed following the application of
India Ink and classified into four grades [Grade 1(intact surface), Grade 2 (minimal fibrillation),
Grade 3 (overt fibrillation) and Grade 4 (erosion)]
as previously described [19].
EXTRACTION OF RNA AND SYNTHESIS OF FIRST-STRAND
CDNA
Synovium (entire tissue) around the infrapatel-
lar fat pads and cartilage tissue from the femoral
condyle and the tibial plateau were harvested from
the gross morphologically evaluated knees. Carti-
lage tissue or synovium from rabbit knees of the
same Grade of OA were pooled and immediately
frozen in liquid nitrogen.The frozen tissue was
crushed and homogenized in 4 ml of 4 M guanidin-
ium thiocyanate containing 25 mM Na-citrate,
0.5% Na-sarkosyl and 0.1 M 2-mercapto-ethanol.
Total RNA was extracted by the acid-guanidinium-
thiocyanate-phenol-chloroform method as pre-
viously described [20]. Chang et al. [21], using a
video imaging technique to quantify India ink
staining, demonstrated that the OA grade of the
condyles and tibial plateau were correlated. There-
fore, in order to obtain enough cartilage for RNA
extraction, we determined the OA grade on the
femoral condyles and pooled the cartilage from
both the femoral condyles and the tibial plateau.
Enough RNA could not be extracted to assess the
expression of MMP-3, IL-1â and TIMP-1 in a small
number of Grade 3 specimens. Therefore, we chose
to use RNA from Grade 1, 2, or 4, respectively, in
both HA and no injection groups. Total RNA
extracted from the untreated rabbits was used as a
normal control. To ensure that PCR amplification
from contaminating genomic DNA would not
a#ect the data, total extracted RNA was treated
with 10 units/ml of RNase-free DNase (RQ1, Fisher
Scientific, Pittsburgh, PA) at 42)C for 30 min.
DNase was then removed by extraction and
ethanol precipitation. Two micrograms of total
RNA were incubated at 65)C for 5 min, chilled on
ice, and reverse-transcribed in a final volume of
100 ìl containing 10 ìl 10#PCR reaction bu#er
(Promega Co. Madison, WI), 5 mM MgCl2, 1 mM
each of dATP, dCTP, dGTP, and dTTT (Promega
Co.), 2.5 ìM oligo (dT)16 primer, 100 units RNasin
(Ribonuclease inhibitor, Promega Co.), and 2500
units M-MLV reverse transcriptase (Promega Co.).
The mixture was incubated at 42)C for 1 h, heated
to 94)C for 10 min, and stored at "20)C.
POLYMERASE CHAIN REACTION (PCR)
First strand cDNA for MMP-3, IL-1â and TIMP-1
was amplified by polymerase chain reaction (PCR).
184 K. Takahashi et al.: HA effect on gene expression in OAIn order to ensure the quality of the RNA prep-
aration and to normalize the RT-PCR protocol,
â-actin RT-PCR products were also produced for
all samples. cDNA was heated to 94)C for 10 min
and cooled on ice for 5 min. cDNA (5 ìl) was added
to a 50 ìl reaction mixture containing 5 ìl
10#PCR reaction bu#er (Promega Co.), 2.5 mM
MgCl2, 20 ìM of each dATP, dCTP, dGTP, and
dTTT (Promega Co.), 200 nM of each priming
oligomer, and 1.0 unit Taq DNA polymerase
(Promega Co.). Primers used for rabbit MMP-3,
IL-1â, TIMP-1 and â-actin were as follows [22–25].
MMP-3: sence, 5*-TTCCCTGGCACCCCAAAGTG-
3*, position 361–380; antisence, 5*-AATCCTGAGG
GACTT-GCGCC-3*, position 998–1017; IL-1â: sence,
5*-TGCTGTCCAGACGAGGGCAT-3*, position 184–
203; antisence, 5*-ACTCTCCAGCTGCAGGGTAG-
3*, position 638–657; TIMP-1: sence, 5*-ACCTTGTC
ATCAGGGCCA-3*, position 131–148; antisence,
5*-ACAGGCAAACACTGTGCA-3*, position 463–
480; â-actin: sence, 5*-ACGTTCAACACGCCGG
CCAT-3*, position 376–395; antisence, 5*-GGATGT
CCACGTCGCACTTC-3*, position 849–868. Ampli-
fication was performed using a DNA thermal
cycler (GeneAmp PCR System 2400, Perkin Elmer,
Norwalk, CT) for 35 cycles. A cycle profile con-
sisted of 30 sec at 94)C for denaturation, 30 sec
at 58)C for annealing, and 45 sec at 72)C for
extention. Electrophoresis of 10 ìl of the reaction
mixture on a 1.5% agarose (Fisher Scientific) gel
containing ethidium bromide was performed to
evaluate amplification and size of generated frag-
ments. 100 bp DNA Ladder (GIBCO BRL Co.,
Gaithersburg, MD) was used as a standard size
marker. National Institute of Health analysis soft-
ware (version 1.60; National Institute of Health,
Bethesda, MD) was used to scan the RT-PCR
agarose gels after photographic documentation.
The software measures relative mean density over
a fixed gray scale range after correction for
background.
QUANTIFICATION OF TIMP-1 MRNA BY RT-PCR
Template cDNA of TIMP-1 was obtained in the
following manner to assess the kinetics of PCR.
The 349 bp RT-PCR product amplified from rabbit
fibroblast mRNA by using the specific primer sets
[24] was subcloned into pGEM-T (Promega Co.)
and purified. Serially diluted TIMP-1 templates of
107–104 copies/ìl were prepared. Six ìl of each
template were amplified in a 60 ìl reaction mixture
by PCR for 38 cycles by using a step-cycle program
of 30 sec at 94)C for denaturation, 30 sec at 58)C for
annealing, and 45 sec at 72)C for extention. Five ìl
of the reaction mixture was removed at every othercycle from 16 to 38 cycles and electrophoresed on
1.5% agarose gels. We analyzed all samples of
cDNA from OA and control rabbits the same way.
Results
GROSS MORPHOLOGICAL ASSESSMENT
All specimens from the ACLT knees exhibited
complete transection of the ACL at death. Twenty
percent (two of 10) ACLT condyles from the HA
injection group showed Grade 1 (intact articular
cartilage surface) [Fig. 1(a)], while none of the no
injection group showed Grade 1. Two of 10 con-
dyles from the HA injection group and two of eight
from the no injection group showed Grade 2 (mini-
mal fibrillation on the articular cartilage surface)
[Fig. 1(b)] and two of the HA injection group and
one of the no injection group developed Grade 3
(overt fibrillation) [Fig. 1(c)]. Five of eight con-
dyles from the no injection group developed Grade
4 damage [Fig. 1(d)]. Four of 10 condyles from the
HA injection group also showed full-thickness
ulceration of the articular cartilage. Averaged
scores of the HA and no injection groups were
2.8 and 4.0, respectively. The extent and grade of
cartilage damage in the HA injection group was
less severe than in the no injection group (Fig. 2).
All knees from untreated rabbits (normal controls)
had intact cartilage (Grade 1).
ASSESSMENT OF THE EFFECT OF HYALURONAN ON MMP-3
AND IL-1â MRNA EXPRESSION BY RT-PCR
Triplicate experiments for each PCR yielded
nearly identical results. Figures are those of the
representative cases of the repeated experiments.
PCR products for â-actin were clearly detected
in RNA preparations from all synovium [Fig. 3(c)]
and cartilage [Fig. 3(d)], which confirmed uniform-
ity of RNA preparation. mRNA for MMP-3 was
slightly detected in normal synovium and Grade 2
of the HA injection group and was upregulated in
Grade 4 of both HA and no injection groups, while
MMP-3 expression was completely suppressed in
Grades 1 and 2 of the HA injection group [Fig.
3(a)]. In normal cartilage, no MMP-3 mRNA was
detected. An upregulation of MMP-3 expression
was observed along with the progression of OA in
the no injection group. The HA injection group
showed MMP-3 expression in Grade 1 and upregu-
lation in Grades 2 and 4 of articular cartilage [Fig.
3(b)]. IL-1â expression was detected in control
synovium and was upregulated in the Grade 4 of
both HA and no injection groups, while being
suppressed in Grades 1 and 2 of the HA injection
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in any cartilage. TIMP-1 mRNA expression was
detected in all samples by RT-PCR, and the
expression seemed to be similar.
ASSESSMENT OF THE EFFECT OF HYALURONAN ON TIMP-1
mRNA EXPRESSION BY RT-PCR
In order to further analyze TIMP-1 expression,
quantification of mRNA by RT-PCR was per-
formed. Serially diluted TIMP-1 templates were
used for PCR to assess the kinetics of PCR of this
fragments. As shown in Fig. 5, PCR was performed
for 16–38 cycles at 2-cycle intervals. The amount of
PCR products increased exponentially in the early
cycles of the reaction and reached a plateau. The
more cDNA exists, the earlier the ethidium-
bromide luminescence of products showed up and
reached a plateau level. The cycles in the middle
of exponentially increasing period quantitatively
reflected the amount of the initial template. Table
I indicates the cycles in the middle of exponen-
tially increasing period in PCR for serially diluted
templates and for samples of cDNA from normal
control or ACLT rabbits. TIMP-1 expression was
upregulated in Grade 4 in both HA and no injec-
tion groups in synovium; however, no di#erence
was observed between the HA and no injection
groups. In cartilage, no di#erences were observed
among samples.Discussion
Since OA in humans is most commonly a slowly
progressive disease and its onset is not ordinarily
definable, the development of the disease is di$-
cult to study. We previously characterized the
ACLT rabbit joints model and demonstrated its
validity to study the development of OA. This OA
model showed mild OA changes in all joints as
early as 4 weeks after ACLT, whereas OA pro-
gressed in 40% of joints to develop full thickness of
ulceration (Grade 4) by 8 weeks. By 12 weeks 60%
of joints developed Grade 4 OA [19]. We also
demonstrated a therapeutic e#ect of HA during
development of OA by administering HA using a
similar model [14, 15]. In the present study, ACLT
rabbits in the no injection group developed Grade
4 OA in 63% of operated knees 9 weeks after ACLT
while this grade was decreased to 40% of the
condyles in the HA injection group. These results
confirm the consistency and reproducibility of the
OA model as well as the e#ect of HA during the
development of OA. While the optimal protocol of
HA treatment for rabbits is uncertain, we kept the
number of injections similar to that used clinically
for humans as well as maintaining consistency
with our previous studies [14, 15]. The volume of
injected solution (0.3 ml) was determined to be the
maximum amount injectible without increasing
joint fluid pressure.FIG. 1. Gross morphological change of the femoral condyles during developing OA. (a) Grade 1 specimen showing
smooth cartilage surface and normal appearance. (b) Grade 2 specimen showing minimal fibrillation of articular
cartilage. (c) Grade 3 specimen showing overt fibrillation on the medial condyle. (d) Grade 4 specimen. Full-thickness
ulceration is marked on the medial condyle along with overt fibrillation on the lateral condyle.
186 K. Takahashi et al.: HA effect on gene expression in OAIncreased attention has been focused on the
involvement of enzymatic pathways associated
with the degradation of extracellular matrix and
its regulation by several cytokines. This study
yielded data relating to this topic. This study
showed that mRNA expressions of MMP-3 in car-
tilage and synovium and IL-1â and TIMP-1 in
synovium were upregulated in experimental OA.
MMP-3 mRNA expression in human OA synovium
was reported to be enhanced [26] as well as the
MMP-3 protein levels in human OA cartilage
and synovium [9]. Previous studies also showed
upregulation of TIMP-1 mRNA expression in
human OA synovium and cartilage [26]. The level
of IL-1â is reported to be increased in human and
experimental OA in cartilage and synovium [7, 8].
Our results are consistent with these studies.
This study also showed that HA downregulated
MMP-3 and IL-1â expression in synovium from 4
animals showing mild OA [Grade 1 (N=2) and
Grade 2 (N=2)]. A previous study demonstrated
the suppression of synovial hyperplasia by HA
following induction of OA in a similar model [14].
IL-1â is one of the most potent proinflammatory
cytokines and has been shown to induce the pro-
duction of MMP-3 [9], as well as prostaglandin
(PG) [10]. The results of this study provides
additional evidence of an antiinflammatory e#ect
of HA on synovium during early stages of OA.
Several explanations can be proposed to account
for this suppression following HA administration.The protective e#ect of HA on cartilage might
a#ect the expression of catabolic mediators in the
synovium. A variable degree of synovial inflam-
mation frequently observed in OA is believed to be
secondary to the cartilage breakdown while
inflamed synovium might result in increased syn-
thesis of proteases leading to cartilage matrix
breakdown. In an in-vitro study, it was shown that
HA could inhibit GAG release from the cartilage
tissue [16]. However, we compared expression of
mediators between the samples with the same
grade of cartilage degeneration. Alternatively, it
could be argued that HA has a direct e#ect on
synovial tissue by decreasing MMP-3 and IL-1â
expression. Some antiinflammatory e#ects of HA
on synoviocytes have been described in vitro. The
levels of PGE2 released by synovial cells in
response to IL-1Æ activation was suppressed by HA
[17]. In one study, HA was shown to inhibit arachi-
donic acid released from the synovial cells in a
concentration and MW-dependent manner [18].
These direct antiinflammatory e#ects of HA on
synovial cells might suppress MMP-3 expression
secondary to IL-1â. There is also a possibility that
HA may suppress the basal expression level of
MMP-3 and IL-1â in synovium. While HA down-
regulates MMP-3 and IL-1â in synovium during the
early stages of OA, it seemed to have no e#ect on
MMP-3, IL-1â and TIMP-1 expression in synovium
from joints having more advanced OA.FIG. 2. Gross morphological assessment of the femoral condyles from the HA injection group (N=10) and the no
injection group (N=8). Note that the grade of cartilage damage in the HA injection group was less severe than in the
no injection group.
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sion in the progressed grade of OA. However,
MMP-3 expression seemed to be enhanced by HA
during the early stages of OA. One related study
has shown that HA enhanced MMP-3 activity in
isolated bovine articular chondrocyte culture [27].
However, it was reported that HA did not pen-
etrate into normal cartilage tissue but coatedcartilage surface while deep intrusion was
observed in severely damaged OA cartilage tissue
[28]. Therefore, it seems unlikely that injected HA
would dramatically influence gene expression in
chondrocytes in intact or nearly intact cartilage.
It may be possible that HA inhibited cartilage
degeneration and improved OA grade in spite
of its lack of e#ect on MMP-3 expression inFIG. 3. RT-PCR of MMP-3 (a and b) and â-actin (c and d). One hundred nanogram of total RNA from synovium (a
and c) and cartilage (b and d) from each grade of OA were used for all amplifications. lane1: Normal control. Lane 2:
Grade 2 of no injection group. Lane 3: Grade 4 of no injection group. Lane 4: Grade 1 of HA injection group. Lane 5:
Grade 2 of HA injection group. Lane 6: Grade 4 of HA injection group. National Institute of Health image analysis
scans of meassuring the relative mean densities of the products are shown at the bottom.FIG. 4. IL-1â mRNA expression in synovium from each grade of OA. One hundred nanograms of total RNA were used
for all RT-PCR. Lane 1: Normal control. Lane 2: Grade 2 of no injection group. Lane 3: Grade 4 of no injection group.
Lane 4: Grade 1 of HA injection group. Lane 5: Grade 2 of HA injection group. Lane 6: Grade 4 of HA injection group.
National Institute of Health image analysis scan measuring the relative mean densities of the products is shown at the
bottom. No IL-1â expression was observed in any cartilage (data not shown).
188 K. Takahashi et al.: HA effect on gene expression in OAcartilage. It should be noted that MMP-3 could be
secreted as a proenzymatic form and activated in
tissue [29].
In the present study, we could clearly detect an
influence of HA on MMP-3 and IL-1â mRNA
expression during development of OA while
TIMP-1 expression was not di#erent between the
groups. Since it was di$cult to detect small di#er-
ences in TIMP-1 expression using ordinary
RT-PCR techniques, we performed a more refined
quantification in order to further analyze TIMP-1
mRNA. Even by this method, however, we could
not establish an e#ect of HA on TIMP-1 expression
in either cartilage or synovium. Specific cell mem-
brane receptors for HA which belong to the CD44adhesion glycoprotein family have now been ident-
ified and allow HA to modulate cell function
directly [30, 31]. The binding of HA to these recep-
tors appears to be molecular weight-dependent. In
addition to the di$culty of intrusion of HA into
intact cartilage, depolymerization or degradation
of injected HA might also arise and explain the
di#erent TIMP-1 results between our in-vivo study
and the in-vitro study which showed an enhance-
ment of TIMP-1 production by HA in bovine
articular chondrocytes cultured in the presence of
IL-1Æ [27].
In conclusion, this study has demonstrated that
intra-articular injection of HA suppressed MMP-3
and IL-1â expression in synovium during the earlyFIG. 5. Kinetics of PCR for TIMP-1 cDNA fragments. Six ìl of serially diluted TIMP-1 templates of 107 (a), 106 (b), 105
(c), and 104 (d) copies/ìl were amplified in a 60 ìl reaction mixture. Five ìl of the reaction mixture was removed for the
electrophoresis at every other cycle from 16 to 30 cycles. Note that the cycles in the middle of the exponentially
increased period quantatively reflected the amount of the initial template. All samples of cDNA from OA and control
rabbits were assessed the same way. A representative electrophoresis of samples was shown (e).Table I
Quantification of TIMP-1 mRNA expression
Templates 107
18
106
20
105
24
104
26
Group Control No injection HA injection
OA Grade 1 2 4 1 2 4
Synovium 24 24 22 24 24 22
Cartilage 22 22 22 22 22 22
The cycles in the middle of the exponentially increased period in PCR for control plasmid templates and
for samples from rabbits were shown. The numbers of cycles were averaged by the results from triplicated
experiments.
Osteoarthritis and Cartilage Vol. 7 No. 2 189stages of OA in an experimental rabbit model. HA
treatment had no e#ect on either MMP-3 or IL-1â
expression in cartilage at all grades of OA or on
MMP-3 expression in synovium at a progressed
grade despite the delay in morphological degener-
ation of cartilage. TIMP-1 expression was not
influenced by HA. These results suggest that one
of the mechanisms of the therapeutic e#ect of
HA is downregulation of MMP-3 and IL-1â in
synovium during early development of OA.References
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